Article Text

Download PDFPDF
CASE REPORT
DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis
  1. Simonette Padron1,
  2. Everett Rogers1,
  3. Michelle Demory Beckler2 and
  4. Marc Kesselman3
  1. 1 Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, Florida, USA
  2. 2 Department of Microbiology, Nova Southeastern University Health Professions Division, College of Medical Sciences, Fort Lauderdale, Florida, USA
  3. 3 Division of Rheumatology, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, Florida, USA
  1. Correspondence to Dr Marc Kesselman, mkesselman{at}nova.edu

Footnotes

  • Contributors Supervised by MK. Patient was under the care of MK. Report was written by SP and ER and was edited by MDB.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors Supervised by MK. Patient was under the care of MK. Report was written by SP and ER and was edited by MDB.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.